Industry News
Nanotubes are beacons in cancer-imaging technique
5/23/2016
Bathing a patient in LED light may someday offer a new way to locate tumors, according to Rice University researchers.
Dietary experiments in mice point the way to early detection of cancer development in humans
5/23/2016
Colorectal cancer is the second most common cause of cancer-related deaths in the Western world, mainly because it is usually diagnosed too late.
Do young, female cancer survivors get enough info about infertility?
5/23/2016
Currently, very few young, female cancer survivors opt for fertility preservation either before or after treatment. New research asks whether there is an information gap.
Liver cancer recurrence may be predictable from protein levels
5/23/2016
Study finds the protein p62 is necessary and sufficient for development of liver cancer in mice and its high expression in non-cancerous liver tissue predicts recurrence in humans.
Combining radiation with immunotherapy showing promise against melanoma
5/20/2016
Combining radiation treatments with a new generation of immunotherapies is showing promise as a one-two-punch against melanoma, Loyola Medicine researchers report in the Journal of Radiation...
You are what you eat: Immune cells remember their first meal
5/20/2016
Scientists at the University of Bristol have identified the trigger for immune cells' inflammatory response - a discovery that may pave the way for new treatments for many human diseases.
Skin cancer could be prevented with 'sunscreen gene'
5/20/2016
Researchers have identified a gene called UVRAG that repairs cellular DNA damage caused by ultraviolet radiation - a primary cause of skin cancer.
FDA approve immunotherapy drug for bladder cancer
5/20/2016
The FDA have given accelerated approval to Tecentriq (atezolizumab), a PD-1/PD-L1 inhibitor, to treat urothelial carcinoma, the most common type of bladder cancer.
Lab cell study shows that HOXA5 protein acts as tumor suppressor in breast cancer
5/20/2016
Many breast cancers are marked by a lack of HOXA5 protein, a gene product known to control cell differentiation and death, and lower levels of the protein correspond to poorer outcomes for patients.
Mouse study: Triple-therapy cocktail shrinks triple-negative breast tumors
5/20/2016
In a new study using mice and lab-grown human cells, a scientific team led by Johns Hopkins Kimmel Cancer Center researchers show how a triple-drug cocktail can shrink triple-negative breast...